The ROE as of September 2024 (TTM) for BioNTech SE (BNTX) is -2.57%

According to BioNTech SE’s latest financial reports and current stock price. The company's current ROE is -2.57%. This represents a change of 272.05% compared to the average of -0.69% of the last 4 quarters.

BioNTech SE (BNTX) Historical ROE (quarterly & annually)

How has BNTX ROE performed in the past?

The mean historical ROE of BioNTech SE over the last ten years is 32.34%. The current -2.57% ROE has changed -107.95% with respect to the historical average. Over the past ten years (40 quarters), BNTX's ROE was at its highest in in the June 2021 quarter at 50.84%. The ROE was at its lowest in in the September 2020 quarter at -22.64%.

BioNTech SE (BNTX) ROE by Quarter and Year

Discovering the peaks and valleys of BioNTech SE ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

BioNTech SE (BNTX) Average ROE

How has BNTX ROE performed in the past?

The current ROE of BioNTech SE (BNTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

BioNTech SE (BNTX) ROE vs. Peers

How is BNTX’s ROE compared to its peers?

BioNTech SE’s ROE is less than Novavax, Inc. (43.70%), greater than CohBar, Inc. (-55.32%), greater than Ginkgo Bioworks Holdings, Inc. (-86.10%), greater than CRISPR Therapeutics AG (-13.85%), less than Ocean Biomedical, Inc. (0%), less than Enveric Biosciences, Inc. (567.07%), greater than Hepion Pharmaceuticals, Inc. (-234.16%), greater than Elevation Oncology, Inc. (-328.66%), greater than AVROBIO, Inc. (-57.97%), less than PTC Therapeutics, Inc. (29.68%), less than Krystal Biotech, Inc. (57.03%), less than Sarepta Therapeutics, Inc. (13.36%), less than Iovance Biotherapeutics, Inc. (5.17%), greater than Madrigal Pharmaceuticals, Inc. (-65.04%), greater than null (-95.61%),

Build a custom stock screener for BioNTech SE (BNTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioNTech SE using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BioNTech SE (BNTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BioNTech SE or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.